New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74.

Authors

Mark S Pearson
Amar R. Jariwala, George Washington University
Giovanni Abbenante
Jordan Plieskatt, George Washington UniversityFollow
David Wilson
Maria Elena Bottazzi
Peter J Hotez
Brian Keegan
Jeffrey M. Bethony, George Washington UniversityFollow
Alex Loukas

Document Type

Journal Article

Publication Date

1-1-2015

Journal

Human Vaccines and Immunotherapeutics

Volume

11

Issue

5

Inclusive Pages

1251-1257

DOI

10.4161/21645515.2014.980199

Keywords

Ancylostoma--enzymology; Ancylostomiasis--prevention & control; Antigens, Helminth--immunology; Aspartic Acid Proteases--immunology; Hookworm Infections--prevention & control; Recombinant Proteins--immunology

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Pearson, M., Jariwala, A. R., Abbenante, G., Plieskatt, J., Wilson, D., Bottazzi, M., Hotez, P., Keegan, B., Bethony, J. M., & Loukas, A. (2015). New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74.. Human Vaccines and Immunotherapeutics, 11 (5). http://dx.doi.org/10.4161/21645515.2014.980199

Peer Reviewed

1

Open Access

1